Cited by 761Protein Kinase Regulation and GTPase SignalingCellular transport and secretionPI3K/AKT/mTOR signaling in cancer

Receptor-induced transient reduction in plasma membrane PtdIns(4,5)P2 concentration monitored in living cells

Open access
Stauffer, Thomas P., Ahn, Seungkril, Meyer, Tobias·1998·Current Biology

Abstract

Although phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) is a well-characterized precursor for the second messengers inositol 1,4,5-trisphosphate, diacylglycerol [1] and phosphatidylinositol 3,4,5-trisphosphate [2], it also interacts with the actin-binding proteins profilin and gelsolin [3], as well as with many signaling molecules that contain pleckstrin homology (PH) domains [4]. It is conceivable that stimuli received by receptors in the plasma membrane could be sufficiently strong to decrease the PtdIns(4,5)P2 concentration; this decrease could alter the structure of the cortical cytoskeleton and modulate the activity of signaling molecules that have PH domains. Here, we tested this hypothesis by using an in vivo fluorescent indicator for PtdIns(4,5)P2, by tagging the PH domain of phospholipase C delta 1 (PLC-delta 1) with the green fluorescent protein (GFP-PH). When expressed in cells, GFP-PH was found to be enriched at the plasma membrane. Binding studies in vitro and mutant analysis suggested that GFP-PH bound PtdIns(4,5)P2 selectively over other phosphatidylinositol lipids. Strikingly, receptor stimulation induced a transient dissociation of GFP-PH from the plasma membrane, suggesting that the concentration of PtdIns(4,5)P2 in the plasma membrane was effectively lowered. This transient dissociation was blocked by the PLC inhibitor U73122 but was not affected by the phosphoinositide (PI) 3-kinase inhibitor wortmannin, suggesting that it is mostly mediated by PLC…

Integrity signals

Registry

Crossref · 10.1016/s0960-9822(98)70135-6

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • PLCδ-PH-GFP associated predominantly with the plasmalemma of RAW cells, with little binding to organellar membranes.

    “As reported for other cell types (Stauffer et al. 1998; Varnai and Balla 1998), PLCδ-PH-GFP associated predominantly with the plasmalemma of RAW cells, with little binding to organellar membranes (Fig. 1 A).”
  • Chimeric constructs of GFP with defined lipid-binding domains of proteins can monitor the distribution of phospholipids and their metabolites in transfected cells.

    “Recent and elegant reports have introduced the use of chimeric constructs of GFP with defined lipid-binding domains of proteins to monitor the distribution of phospholipids and their metabolites in transfected cells (Oancea and Meyer 1998; Oancea et al. 1998; Stauffer et al. 1998; Varnai et al. 1999; Czech 2000).”
  • PLCδ-PH-GFP and C1δ-GFP probes had been validated in other systems and their suitability was confirmed in RAW macrophages.

    “These probes had been validated in other systems (Oancea et al. 1998; Stauffer et al. 1998; Varnai and Balla 1998) and their suitability was confirmed in RAW macrophages.”

Cited by

Sorted by citations

Authors
Stauffer, T. P., Ahn, S., & Meyer, T.
Affiliations
  • Duke Medical Center (US)
  • Duke University (US)
Venue
Current Biology
Publisher
Elsevier BV
Published
1998-03
Volume
8
Issue
6
Pages
343-346
ISSN
0960-9822 (ISSN-L)
OpenAlex
W1983769291
Cited by
761
References
0
Citations by year
2026: 14 · 2025: 30 · 2024: 25 · 2023: 23 · 2022: 24 · 2021: 31 · 2020: 22 · 2019: 24 · 2018: 36 · 2017: 18 · 2016: 16 · 2015: 25 · 2014: 29 · 2013: 24 · 2012: 40
FWCI
10.12
Type
journal article
Language
en
Open access
Locations
  • Current Biology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Procter and Gamble (SRA 1617)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (823A-050457)
  • National Institutes of Health (GM-51457)
  • David and Lucile Packard Foundation
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Keywords
phosphatidylinositol 4,5-bisphosphate, phospholipase C delta 1, pleckstrin homology domain, plasma membrane, receptor signaling, second messengers, U73122, wortmannin, phosphatidylinositol 3-kinase, phospholipid binding
MeSH terms
Androstadienes, Animals, Cells, Cultured, Electrophoresis, Polyacrylamide Gel, Enzyme Inhibitors, Fluoroscopy, Membrane Proteins, Phosphodiesterase Inhibitors, Pyrrolidinones, Transfection, Microscopy, Video, Phosphatidylinositol 4,5-Diphosphate, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review